Funding for this research was provided by:
GSK Biologicals SA (HO-15-15940)
Received: 26 July 2018
Accepted: 29 January 2019
First Online: 6 February 2019
Ethics approval and consent to participate
: Not applicable for modelling studies.
: Not applicable.
: CS, BB, and SC are employed by the GSK group of companies and hold shares in the GSK group of companies as part of their employee remuneration. KH was employed by the GSK group of companies and holds shares as part of her employee remuneration. PW and MB have nothing to disclose. PB reports a grant from the Center for Diseases Control (CCM) in Italy for a project dealing with the disease burden of herpes zoster. AAG reports grants from NIH, personal fees from Merck and the GSK group of companies, and lab support from Merck, outside of the submitted work.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.